Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Warts 3Condylomata Acuminata 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Cantharidin × Clear all
NCT05070754 2024-04-05

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Medical University of South Carolina

Phase 4 Completed
17 enrolled 13 charts

Warts

NCT03625960 2018-08-10

Cantharone for the Treatment of Perenial Warts

Wayne State University

Phase 4 Completed
12 enrolled

Condylomata Acuminata, Warts

NCT01084824 2010-03-11

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

North Idaho Dermatology

Phase NA Completed
70 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡